XOMA Announces $21 Million Underwritten Offering of Common Shares and Warrants Feb 02, 2010 8:45am EST
XOMA Presents Advantages of Its Multiple Antibody Formulation Technologies at Antibody Engineering Conference Dec 10, 2009 9:00am EST